MBL

Anti-MELK (Human) mAb

Product Code:
 
MBL-D373-3
Product Group:
 
Primary Antibodies
Supplier:
 
MBL
Host Type:
 
Mouse
Antibody Isotype:
 
IgG1 κ
Antibody Clonality:
 
Monoclonal
Antibody Clone:
 
11-28
Regulatory Status:
 
RUO
Applications:
  • Immunocytochemistry (ICC)
  • Western Blot (WB)
Shipping:
 
4°C
Storage:
 
-20°C
1 / 1
❮❯

No additional charges, what you see is what you pay! *

CodeSizePrice
MBL-D373-3100 ug/100 uL£365.00
Quantity:
Prices exclude any Taxes / VAT
How to order with us   Contact us
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • Show All

Further Information

Alternative Names:
maternal embryonic leucine zipper kinase, hPK38, HPK38, pEg3 kinase
Applications:
WB - 1 ug/mL ICC - 1-5 ug/mL (Heat treatment is necessary for paraffin-embedded sections.)
Concentration:
100 ug/100 uL
Conjugate:
Unconjugated
Description:
MELK is a member of the AMPK serine/threonine kinase family. It is involved in mammalian embryonic development. Overexpression of MELK protein is also reported in various types of human cancer. MELK plays critical roles not only in cancer cell growth but also in formation or maintenance of cancer stem cells that have the ability to self-renew and differentiate. Emerging evidence indicates that cancer stem cells are resistant to chemotherapy and radiation therapy and are associated with cancer relapse. For these reasons, MELK is considered a promising drug target molecule for cancer treatment.
Formulation:
1 mg/mL in PBS/50% glycerol, pH 7.2
Immunogen Translated:
Recombinant protein, corresponding to amino acids 264-601 of human MELK
Target:
MELK

Documents